KPI-014

N/A

Report date: 2025/12/12 11:02:45

Base Information

Drug NameKPI-014
Drug Alias NameMesenchymal stem cell therapy (KALA BIO)Mesenchymal stem cell therapy (Kala Pharmaceuticals)KPI-014
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionantioxidantImmunomodulatorsNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsStargardt DiseaseRetinitis Pigmentosa
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKALA BIO Inc
China Registration ClassN/A

Develop Information

Active CompaniesKALA BIO Inc
Inactive CompaniesN/A
Active IndicationsStargardt DiseaseRetinitis Pigmentosa
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A